Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 268.89M
March 31, 2025 483.80M
March 31, 2024 420.67M
March 31, 2023 583.39M
March 31, 2022 395.66M
Date Value
March 31, 2021 476.30M
March 31, 2020 168.56M
March 31, 2019 134.81M
March 31, 2018 61.55M
March 31, 2017 20.59M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
PepGen Inc. 148.46M
Oncolytics Biotech, Inc. 5.202M
Sangamo Therapeutics, Inc. 20.95M
Sarepta Therapeutics, Inc. 939.65M
Anixa Biosciences, Inc. 15.17M